Ahead of European Cannabis Week, Grow Group’s Managing Director, Pierre van Weperen, talks to Cannabis Health about the current state of play, and the future of cannabis-based medicine in the UK. More than 6.4 million people in the UK are currently waiting for treatment on the [...]
A national class action has been brought against Aurora Cannabis in Canada, alleging that the company ‘negligently’ failed to warn consumers about the risk of developing Cannabinoid Hyperemesis Syndrome (CHS). On May 14, 2025, the Ontario Superior Court of Justice certified a national class action alleging [...]
A profound change is quietly occurring across the UK, writes James Smith, medical cannabis patient and co-founder of 4C Labs, following a recent experience using cannabis-based medicines to recover from major hip surgery on the NHS. Disclaimer: I am not a doctor or a scientist, this [...]
A new UK study highlights how medical cannabis may improve quality of life for people living with obsessive compulsive disorder (OCD). Researchers at Drug Science analysed data from what they believe to be the largest sample of OCD patients receiving cannabis-based medicines on prescription. OCD is estimated [...]
Two cannabis-derived compounds have shown remarkable effectiveness against fungal pathogens in laboratory tests, according to new research. In a study published in The Journal of Neglected Tropical Diseases (PLOS NTDs), researchers discovered that Cannabidiol (CBD) and Cannabidivarin (CBDV) killed harmful Cryptococcus neoformans – a WHO-listed priority fungal pathogen. [...]
The UK government has commissioned the Advisory Council on the Misuse of Drugs (ACMD) to carry out a formal review of the current state of play regarding cannabis-based medicinal products. Seven years since the first unlicensed cannabis-based medicinal products (CBPMs) were prescribed in the UK, the [...]
The Czech Republic’s Chamber of Deputies has approved a landmark amendment which, if passed through the Senate, will legalise home cultivation of up to three plants, home possession of up to 100g of cannabis per person, and public possession of up to 25g per person. Its [...]
Cannabis use among older adults in the US has reached a new high, with 7% of adults aged 65 and over who report using it in the past month. This is according to an analysis led by researchers with the Center for Drug Use and HIV/HCV [...]
Every year, Men’s Health Week serves as a crucial reminder to pause and reflect on the health challenges that many men face – but often don’t talk about. It’s a time to raise awareness of how gender, culture and environment can affect our health, and to [...]
Words by Dr Sue Clenton, Medical Director, Releaf If we are serious about the future of medical cannabis in the UK, we must be equally serious about its clinical foundations. That means investing not just in science or access, but in a new generation of [...]
Chronic pain affects millions of people in the UK. As the conversation around medical cannabis evolves, many patients and GPs are beginning to explore whether medical cannabis could offer an alternative. In this instalment of our medical cannabis education series, Dr Elisabeth Philipps is joined by [...]
The UK government has rejected a petition calling for patients with a prescription for cannabis-based medicines to be allowed to grow their own plants at home. Around 13,000 people signed a petition calling for ‘Grow Your Own’ laws to allow patients with a prescription for cannabis-based [...]
The Medical Cannabis Clinicians Society (MCCS) has published its first comprehensive guidance specifically for pharmacy professionals involved in the dispensing of cannabis-based medicinal products (CBPMs) in the UK. Pharmacists play a vital role in the dispensing of CBPMs and have a responsibility to ensure these medications [...]
New research sheds light on the impact of cannabis legalisation on prescription drug claims following their implementation in the US. Approval of recreational and medical cannabis laws in most US states has allowed individuals to legally obtain cannabis to treat certain medical ailments that had typically [...]
The first academic research on Switzerland’s landmark adult-use pilot, has reported a decline in problematic consumption, particularly among those who used other drugs in addition to cannabis. Europe’s first adult-use cannabis pilot programme, the Weed Care study, launched in Basel, Switzerland, in January 2023, to examine [...]
Denmark has officially passed legislation which will solidify its long-running medical cannabis pilot programme as a permanent fixture of its national healthcare system in what has been described as a ‘victory for patients’. First announced in November 2024, the medical cannabis bill (L135) has undergone an [...]
If you’ve been prescribed medical cannabis flower, it’s recommended you administer your medicine with a medical-grade vaporiser. Smoking medical cannabis is illegal, but it also exposes you to harmful toxins. Vaporising heats the cannabis flower without combustion, preserving its active compounds while avoiding the harmful byproducts [...]
Despite being one of the most important regulatory systems in human physiology, the endocannabinoid system (ECS) remains inexplicably absent from almost all mainstream medical education. A report published by Volteface in 2022 found that in the UK, while around 40,000 clinicians are eligible to prescribe medical cannabis, only [...]
The ‘remarkable’ mother and campaigner, who played a pivotal role in the legalisation of medical cannabis in the UK, Hannah Deacon, has died at the age of 45. In a statement on her website, Hannah’s loved ones said they were ‘heartbroken’ to share the news of [...]
New analysis from the UK has found that cannabis-based medicines are associated with improvements in symptoms and overall quality of life in patients with treatment-resistant epilepsy. Researchers say the study, which analysed data from the UK Medical Cannabis Registry (UKMCR), shows the ‘promising potential’ of cannabis-based [...]
After a six-year battle on behalf of campaigners, Romania’s Health Committee has rejected a bill which would broaden access to medical cannabis products on prescription. Following what has been described as “six years of silence”, in February, Romania’s Health Committee of the [...]
Dying Matters Awareness Week encourages open conversations about end-of-life care, helping to break the stigma around death and dying. This year’s discussions feel particularly timely, as the UK’s Terminally Ill Adults (End of Life) Bill moves forward[1]. If passed, the bill could change the future of [...]
New research reveals that the use of cannabidiol (CBD) cannabis extract can lead to meaningful benefits and improve behaviour in children and teenagers with autism spectrum disorder (ASD). ASD affects approximately one in 100 children around the world and symptoms can include difficulty interpreting language, difficulty [...]
A new pilot study has examined how medically supervised cannabis use in a residential recovery home may support people in treatment for substance use challenges. The study, recently published in the Journal of Studies on Alcohol and Drugs, was conducted by researchers from UBC Okanagan and [...]
A cannabis executive is calling for law enforcement agencies to be better educated on medical cannabis, after a court ruled UK border force officers wrongfully seized his prescription. The managing director of the Canndr medical cannabis platform has spoken publicly for the first time after winning [...]
The largest meta-analysis of scientific data on medical cannabis’ viability in cancer treatment to date has been published, finding overwhelmingly positive consensus for its therapeutic potential. In a comprehensive review drawing on a dataset of over 10,000 peer-reviewed publications and nearly 40,000 associated data points, the Whole Health Oncology [...]
Patients prescribed medical cannabis in Australia maintained improvements in overall health-related quality of life (HRQL), fatigue, and sleep disturbance across a one-year period, according to new research. The study, published in the journal PLOS One by researchers at the University of Sydney, also found that anxiety, [...]
As the UK’s fastest-growing medical cannabis clinic, Releaf is committed to not only addressing an unmet healthcare need but doing so in a safe and clinically responsible manner. This is even more important with the medical cannabis industry coming under closer scrutiny from regulators such as [...]
The U.S. cannabis brand STIIIZY is expanding its footprint with the opening of its newest retail location in Hawthorne, CA on April 12th. As the brand’s 44th dispensary, the new storefront is located at 12831 Crenshaw Blvd, Hawthorne, CA. Perfectly located on Crenshaw Blvd [...]
The number of pregnant women using cannabis in the US has more than tripled over the last two decades, with researchers calling for further studies to inform intervention approaches. Cannabis use has been increasing during pregnancy, according to researchers at Columbia University Mailman School of Public [...]
Scientists at the University of South Australia say they have developed an innovative solution to improve the effectiveness of cannabidiol to treat epilepsy, multiple sclerosis and other neurodegenerative diseases. Cannabidiol (CBD), the non-psychoactive compound found in the cannabis plant, is widely prescribed for its analgesic, anti-inflammatory [...]
France’s four-year campaign to launch a fully regulated generalised medical cannabis framework is finally being realised. Just weeks ago thousands of participants in Frances’ medical cannabis ‘experiment’, launched in 2021, were preparing to wean themselves off the treatment and had been instructed by the government to [...]
The cannabis sector faces a multifaceted landscape marked by economic challenges, shifting regulations and market volatility. Thriving in this environment requires industry businesses to move beyond reactive measures, embracing forward-looking risk management strategies. By adopting comprehensive mitigation plans and maintaining proactive vigilance, cannabis companies can stay [...]
UK adults remain confused about the legal status and availability of medical cannabis, despite it being legalised in 2018, a new survey has revealed. According to a new study of 2,000 adults, while four in every five respondents (79%) were aware of medical cannabis, only 26% [...]
Releaf is one of the first medical cannabis clinics to integrate with the NHS’ Spine service, the digital backbone of healthcare across the UK. Could this be a turning point in how clinicians view and engage with cannabis-based medicines? While the number of prescriptions for CBMPs [...]
Last week, the 68th session of the United Nations Commission on Narcotic Drugs (CND) voted almost unanimously to place hexahydrocannabinol (HHC) under Schedule II of the 1971 Convention. After over a year of warnings from various international health bodies and individual efforts from a swathe of countries [...]
A new study has found certain cannabis terpenes to be effective at relieving post-surgical and fibromyalgia pain in preclinical models. Research from the University of Arizona Health Sciences and funded by the National Institute of Health, suggests that terpenes from the Cannabis sativa plant may be [...]
The concept of the medical cannabis card originated out of the US in some jurisdictions where patients are issued an annual card from their doctor which permits them to purchase medical cannabis from any legal dispensary. Although the markets in Europe differ significantly to those in [...]
Written by SOMAÍ Pharmaceuticals CEO, Michael Sassano For years, medical cannabis has been treated as a commodity, with little emphasis on brand differentiation. However, as the market evolves, established cannabis brands are playing an increasingly critical role in patient care, physician confidence, and regulatory acceptance, mirroring [...]
Scientists have developed a new compound to harnesses the pain-relieving properties of cannabis without any unwanted side effects, pointing to a possible alternative to opioids. In the search for alternative pain relievers, researchers at Washington University School of Medicine in St. Louis and Stanford University have [...]
In a new survey of UK doctors, 84% said they would be open to prescribing medical cannabis for chronic pain if it were part of the NHS toolkit. The findings indicate there may be significant support among doctors for widening access to medical cannabis for the [...]
Network Rail’s policy breaches the Equality Act 2010. PatientsCann UK fights for fair treatment—take action now.
The post Network Rail’s Response to Our Concerns: A Call for Fair and Transparent Policy first appeared on PatientsCann UK.
When it comes to medical cannabis, quality and consistency aren’t just nice-to-haves, they’re the whole deal. Patients depend on it to manage conditions like epilepsy, chronic pain, and PTSD, not for a surprise mystery grab bag of effects. If potency or purity wavers, so does the treatment, and that’s a no-go. A rock-solid supply chain […]
The post Why Your Medical Cannabis Shouldn’t Be a Game of Chance! appeared first on I Am Billy.
Yep, you can hit the road with your prescribed medical cannabis – but there are a few golden rules: • You must not be impaired (no zombie-mode driving). • Your prescription comes from a specialist consultant (not your mate Dave). • You can prove it (because “trust me, bro” won’t cut it). The DVLA says doctors should clue […]
The post Driving on Medical Cannabis UK: Can You? appeared first on I Am Billy.
The government is currently tinkering with disability benefits, but for millions of disabled folks, these aren’t just numbers on a spreadsheet, they’re the difference between making it through the month or free-falling into financial chaos. They are taking away a lifeline! Picture this: You rely on medical cannabis to keep your epilepsy, multiple sclerosis, or […]
The post The Terrifying High Price of Cutting Disability Benefits & Medical Cannabis in the UK appeared first on I Am Billy.
The preliminary findings from Switzerland’s seven active pilot trials, involving around three per cent of the country’s active cannabis consumers, have been published by a local university. Just days after Switzerland announced it was positioning itself to become the first European country to launch a full commercial adult-use [...]
In a new research paper, mothers using medical cannabis to manage their health say it helps them to be ‘more present’ and ‘tolerant’ parents. A new study, funded by the Health Research Council of New Zealand, has explored the experiences of mothers using medical cannabis to [...]
A new study is shaking things up! Turns out, prescription cannabis might just be the ultimate life hack for folks 50 and older struggling with pain and sleep issues. Researchers found that prescription cannabis isn’t just safe but actually effective in easing pain, improving sleep, and boosting overall quality of life. The Highlights: 229 participants […]
The post Breaking: Grandparents & Prescription Cannabis appeared first on I Am Billy.
Cannabinoid therapy is the rising star of pain relief, nausea control, and neurological care. But here’s a fun fact – if your liver is running on low power (thanks to cirrhosis, hepatitis, or other party-crashers), your cannabinoid dose might need a remix! Your liver is the backstage crew for metabolizing THC and CBD, mainly using […]
The post Cannabinoid Therapy & Liver Health: Why One Size Doesn’t Fit All appeared first on I Am Billy.
OxyContin was introduced in 1996 as a revolutionary painkiller, with Purdue Pharma assuring doctors and patients that it was safe and had a low risk of addiction. This was a blatant lie. The drug was a powerful opioid, chemically similar to heroin, and highly addictive. Purdue’s aggressive marketing campaign targeted not only chronic pain patients […]
The post What if we had Ditched Deadly OxyContin and Embraced Live-Giving Alternatives Instead? appeared first on I Am Billy.
Copyright © 2020 – 2025 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
